2018 American Transplant Congress
Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation
Organ Transplant Program, Swedish Medical Center, Seattle, WA.
Anti-thymocyte globulin (ATG) is used as induction immunosuppression in kidney transplantation to prevent allograft rejection. ATG causes dose-dependent lymphocyte depletion, yet optimal dose is unknown.…2018 American Transplant Congress
Surveillance for Mycoplasma/Ureaplasma Infection in Lung Transplant Recipients (LTRs)
University of Alberta, Edmonton, AB, Canada.
Introduction: An association with Ureplasma urealyticum, Ureaplasma parvum and Mycoplasma hominis infections has been proposed to play a causative role in hyperammonemia syndrome (HS), a…2018 American Transplant Congress
Prevalence and Infection-Related Outcomes Associated with Transplant Tourism
Transplant Infectious Diseases, Toronto General Hospital, Toronto, ON, Canada.
Background:Patients who receive organ transplants via transplant tourism may have a greater risk of complications. We sought to describe the infectious risks associated with this…2018 American Transplant Congress
Use of Granulocyte Colony-Stimulating Factor for Leukopenia Post-Renal Transplant
Purpose: Leukopenia is a frequent complication in renal transplant recipients (RTRs). Granulocyte colony-stimulating factor (G-CSF) accelerates white blood cell (WBC) count recovery; but, published experience…2018 American Transplant Congress
Intestinal Microbiome Diversity is Associated with Liver Disease Etiology and Predicts Post-Liver Transplant Mortality
Medicine, Columbia University, New York, NY.
Background: Dysbiosis of the intestinal microbiome is common among patients with decompensated liver disease and has been associated with disease progression as well as life-threatening…2018 American Transplant Congress
Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation
Background:Influenza infection in transplant patients can be severe but factors predictive of outcome in this setting are unclear. The aim of the study was to…2018 American Transplant Congress
Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia
Purpose: Ganciclovir-resistant cytomegalovirus (GR-CMV) is serious complication after transplantation. Recurrence after primary GR-CMV infection is common, with literature defined rates of approximately 20-30%. It is…2018 American Transplant Congress
The Impact of the Influenza Vaccine on Pediatric Kidney Transplant Outcomes
The influenza vaccine has been associated with de novo DSA and rejection in adult kidney recipients. This risk has not been adequately assessed in pediatric…2018 American Transplant Congress
You've Gotta Have HOPE: Seeking HIV Donors in a Large US OPO
1LiveOnNY, NY; 2Medicine, Mount Sinai School of Medicine, NY.
Passage of the HOPE Act in 2013 led to important workflow changes within a large US organ procurement organization (OPO). The initial triage process for…2018 American Transplant Congress
A National Survey of Valganciclovir Dosing Strategies in Pediatric Solid Organ Transplant Recipients
Objective: The FDA-approved pediatric indication of valganciclovir (VGCV) is limited to cytomegalovirus (CMV) prophylaxis in heart and kidney transplants. The recommended regimen is a daily…
- « Previous Page
- 1
- …
- 58
- 59
- 60
- 61
- 62
- …
- 84
- Next Page »